Cargando…

1479. Evaluating the Impact of Procalcitonin on Antibiotic Utilization in Chronic Obstructive Pulmonary Disease Exacerbations

BACKGROUND: Antibiotic prescription rates for treating exacerbations of chronic obstructive pulmonary disease (COPD) have been reported as high as 90% in the United States. Research has shown that over 50% of COPD exacerbations are due to viral etiologies. Elevations in procalcitonin (PCT) levels ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Kevin, Dempsey, Casey, Patel, Shivani, Butler, John, Septimus, Edward
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252594/ http://dx.doi.org/10.1093/ofid/ofy210.1308

Ejemplares similares

1336. Impact of Procalcitonin-Guided Antibiotic Management in Chronic Obstructive Pulmonary Disease Exacerbation and Community-Acquired Pneumonia
por: Triner, Molly, et al.
Publicado: (2019)

173 Introduction of Procalcitonin Testing Did Not Reduce Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Rao, Krishna, et al.
Publicado: (2014)

Introduction of Procalcitonin Testing and Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Ulrich, Robert J, et al.
Publicado: (2019)

Antibiotic Treatment of Severe Exacerbations of Chronic Obstructive Pulmonary Disease with Procalcitonin: A Randomized Noninferiority Trial
por: Verduri, Alessia, et al.
Publicado: (2015)

Procalcitonin-guided antibiotic therapy in acute exacerbation of chronic obstructive pulmonary disease: An updated meta-analysis
por: Li, Zhuying, et al.
Publicado: (2019)

Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note
por: Falsey, Ann R, et al.
Publicado: (2012)

Procalcitonin for Antibiotic Prescription in Chronic Obstructive Pulmonary Disease Exacerbations: Systematic Review, Meta-Analysis, and Clinical Perspective
por: Chen, Ken, et al.
Publicado: (2020)

2013. Procalcitonin Current State Evaluation Within a Large Health System
por: Pena, Kelsey, et al.
Publicado: (2018)

1479 Evaluation of Tularemia Courses: A Multicenter Study From Turkey
por: Erdem, Hakan, et al.
Publicado: (2014)

Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease
por: Lacoma, Alicia, et al.
Publicado: (2011)

325. Empiric Antibiotics for COVID-19 and the Utility of Procalcitonin
por: Desens, Adrienne D, et al.
Publicado: (2021)

Draft Genome Sequences of Synechococcus sp. strains CCAP1479/9, CCAP1479/10, CCAP1479/13, CCY0621, and CCY9618: Five Freshwater Syn/Pro Clade Picocyanobacteria
por: Druce, Elliot, et al.
Publicado: (2023)

Procalcitonin-Guided Antibiotic Use in Acute Exacerbations of Idiopathic Pulmonary Fibrosis
por: Ding, Juanjuan, et al.
Publicado: (2013)

Antibiotic Retreatment for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Sethi, Sanjay, et al.
Publicado: (2020)

Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Song, Wen, et al.
Publicado: (2021)

Procalcitonin: Is it a predictor of noninvasive positive pressure ventilation necessity in acute chronic obstructive pulmonary disease exacerbation?
por: Pazarli, Ahmet Cemal, et al.
Publicado: (2012)

1479. Analysis of Depression in People Living with Human Immunodeficiency Virus (HIV) During the Coronavirus Disease 2019 Pandemic in 4 African Countries
por: Adjei, Paul, et al.
Publicado: (2023)

1339. Impact of Implementing Procalcitonin Testing with Comprehensive Education on Procalcitonin Ordering Habits and Antibiotic Usage
por: Johnsrud, Joyce, et al.
Publicado: (2019)

Ability of procalcitonin to distinguish between bacterial and nonbacterial infection in severe acute exacerbation of chronic obstructive pulmonary syndrome in the ICU
por: Daubin, Cédric, et al.
Publicado: (2021)

Procalcitonin kinetics to guide sequential invasive-noninvasive mechanical ventilation weaning in patients with acute exacerbation of chronic obstructive pulmonary disease and respiratory failure: procalcitonin’s adjunct role
por: Lin, Shao-Hua, et al.
Publicado: (2021)

Capsule Commentary on Bremmer et. al., Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations
por: Mathioudakis, Alexander G.
Publicado: (2018)

The Use of Serum Procalcitonin as a Diagnostic and Prognostic Biomarker in Chronic Obstructive Pulmonary Disease Exacerbations: A Literature Review Update
por: Pantzaris, Nikolaos-Dimitrios, et al.
Publicado: (2018)

Procalcitonin, C-reactive protein, PaCO(2), and noninvasive mechanical ventilation failure in chronic obstructive pulmonary disease exacerbation
por: Wang, Jinrong, et al.
Publicado: (2019)

The predictive value of serum procalcitonin for non-invasive positive pressure ventilation in the patients with acute exacerbation of chronic obstructive pulmonary disease
por: Liu, Linlin, et al.
Publicado: (2021)

Impact of pulmonary hypertension in patients with acute exacerbation of chronic obstructive pulmonary disease and its effect on healthcare utilization
por: Munshi, Rezwan F., et al.
Publicado: (2021)

1479. Clinical Efficacy and Safety Analysis Evaluating Oral Gepotidacin (GSK2140944) from a Phase IIa Study in the Treatment of Uncomplicated Urinary Tract Infections
por: Overcash, J Scott, et al.
Publicado: (2019)

Pantoea agglomerans: An Elusive Contributor to Chronic Obstructive Pulmonary Disease Exacerbation
por: Shrestha, Binav, et al.
Publicado: (2021)

Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease
por: Hasegawa, Kohei, et al.
Publicado: (2014)

Exacerbations of Chronic Obstructive Pulmonary Disease
por: Garvey, Christine, et al.
Publicado: (2012)

The Chronic Obstructive Pulmonary Disease Exacerbation
por: Sherk, Peter A., et al.
Publicado: (2000)

Exacerbation of Chronic Obstructive Pulmonary Disease
por: Zhou, Xianghui, et al.
Publicado: (2015)

Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
por: Mathioudakis, Alexander G., et al.
Publicado: (2017)

Relationship between serum procalcitonin level and chronic obstructive pulmonary disease
por: Borsi, Hamid, et al.
Publicado: (2019)

Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review
por: Puhan, Milo A, et al.
Publicado: (2007)

Exacerbations of chronic obstructive pulmonary disease: When are antibiotics indicated? A systematic review
por: Puhan, Milo A, et al.
Publicado: (2008)

Impact of Procalcitonin (PCT)-Guided Antibiotic Management on Antibiotic Exposure and Outcomes: Real World Evidence
por: Broyles, Michael
Publicado: (2017)

P12 Partial implementation of procalcitonin measurement as an antibiotic stewardship in the ICU
por: Gill, Simon, et al.
Publicado: (2023)

2194. Procalcitonin-Guided Antibiotic Strategy for Lower Respiratory Tract Infections: Outcomes and Safety of Withholding Antibiotics
por: Bambino Geno Tai, Don, et al.
Publicado: (2019)

Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Segal, Leopoldo N., et al.
Publicado: (2015)

Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_bgrlorljvc7r7ebtf3g050dkkg